कोशिश गोल्ड - मुक्त
"Awareness and consistent training are needed with the growing demand for effective skin treatments in India"
Bio Spectrum
|September 2025
India’s dermatology and aesthetic market is reportedly among the fastest-growing globally, projected to grow at a CAGR of 10.11 per cent from 2025 to 2032.

Madhusudhan HK, Country Manager, Aerolase, India
However, there remains a significant gap in access to advanced laser solutions that are truly effective, safer, and inclusive of all skin types. Addressing this concern, around the celebration of World Skin Day on July 8, US-based firm Aerolase announced the launch of Neo Elite in India, a US FDA-approved 650-microsecond laser technology that safely and effectively treats a wide range of skin conditions. This development marks a significant step towards Aerolase’s entry into the Indian market and how the brand is poised to reshape the country’s dermatology and aesthetic treatment landscape with its advanced, inclusive, and patient-friendly laser solutions. To find out more about the company’s future plans in India, BioSpectrum India interacted with Madhusudhan HK, Country Manager, Aerolase. Edited excerpts:
How does Aerolase see India as a strategic destination for expanding its advanced dermatology equipment?
India is a key part of our global expansion strategy. The dermatology and aesthetic segment here is growing rapidly, with increasing awareness and demand for non-invasive skincare solutions with no down time. With a strong network of dermatologists, evolving consumer expectations, and rising investments in clinical aesthetics, India offers a dynamic environment for us to introduce our technologies. We see this market as a long-term opportunity to build meaningful partnerships with practitioners and clinics across the country. We aim to offer highly personalised, zero-downtime treatments that are ideal for Indian skin concerns, from pigmentation to acne and rejuvenation. We are also laying the foundation to collaborate with reputed homegrown clinics and brands to scale our presence responsibly and sustainably.
यह कहानी Bio Spectrum के September 2025 संस्करण से ली गई है।
हजारों चुनिंदा प्रीमियम कहानियों और 9,500 से अधिक पत्रिकाओं और समाचार पत्रों तक पहुंचने के लिए मैगज़्टर गोल्ड की सदस्यता लें।
क्या आप पहले से ही ग्राहक हैं? साइन इन करें
Bio Spectrum से और कहानियाँ

Bio Spectrum
Navigating the Complexities of Pharma Packaging Sustainability
Pharma companies in India are increasingly adopting sustainable methods in packaging to ensure that medicines remain safe and the environment is protected. Various initiatives by the government, focusing on reducing carbon footprints, are revolutionising the pharma packaging industry.
8 mins
September 2025

Bio Spectrum
Are BioStartUps in a Funding/Innovation Rut?
At the BioStartUps Founders & Investors Forum 2025, held on August 1, 2025 at the CIDCO Exhibition Centre in Vashi, Navi Mumbai, biotech industry stalwarts deliberated on the country's innovation and startup ecosystem.
10 mins
September 2025

Bio Spectrum
How Do Recent Deaths Impact Gene Therapy Development?
Cell and gene therapy (CGT) is among the most closely watched areas in pharma and biotech.
4 mins
September 2025

Bio Spectrum
HealthQuad appoints Namit Chugh as Director
Quadria Group, Asia's leading healthcare-focused private equity platform, has announced the appointment of Namit Chugh as Director at HealthQuad, India's leading healthcare-focused growth venture capital platform.
1 min
September 2025

Bio Spectrum
Why Is Endoscopy Crucial for Gl Cancer Diagnosis?
The increased demand for gastrointestinal (GI) diagnostics in India, driven by rising disease rates and awareness of early intervention, is not evenly distributed. While major urban hospitals have expanded their endoscopic capabilities, many semi-urban and rural areas face limited access. Addressing this disparity is crucial for extending the benefits of early disease detection across the country.
4 mins
September 2025
Bio Spectrum
New England Biolabs launches NEBNext low-bias small RNA library prep kit
US-based New England Biolabs (NEB) has announced the launch of the NEBNext Low-bias Small RNA Library Prep Kit, designed to minimise biased representation of small RNA species in sequencing data.
1 min
September 2025

Bio Spectrum
Qiagen expands NGS portfolio with launch of QIAseq XHYB long read panels
Qiagen has announced the launch of its new QIAseq xHYB Long Read Panels, a suite of target enrichment solutions designed to unlock long-read sequencing of genomically complex regions.
1 min
September 2025

Bio Spectrum
"Awareness and consistent training are needed with the growing demand for effective skin treatments in India"
India’s dermatology and aesthetic market is reportedly among the fastest-growing globally, projected to grow at a CAGR of 10.11 per cent from 2025 to 2032.
4 mins
September 2025
Bio Spectrum
Dr. Moopen's Legacy Scholarship & Fellowships to aid 25 students from across India
In a path breaking initiative to make medical education accessible to meritorious students and students from economically challenged backgrounds, Padma Shri Dr Azad Moopen, Founder & Chairman of Aster DM Healthcare and a globally recognised philanthropist, has announced an annual scholarship programme Dr. Moopen's Legacy Scholarship & Fellowships Programme aimed at supporting meritorious students seeking admissions in Dr. Moopen's Medical College, Dr Moopen's Nursing College and Dr Moopen's College of Pharmacy in Wayanad, Kerala.
1 min
September 2025

Bio Spectrum
Iberia Pharma set to open manufacturing unit in India with investment of Rs 70 Cr
Gurugram-based Iberia Pharmaceuticals has announced its new hi-tech manufacturing and research facility spread across 60,000 sq. ft. in Jhajjar, Haryana.
1 min
September 2025
Listen
Translate
Change font size